Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines

Gastrointest Endosc. 2015 Apr;81(4):1041-5. doi: 10.1016/j.gie.2014.11.006. Epub 2015 Jan 28.

Authors

Zachary L Smith¹, Young S Oh¹, Kia Saeian¹, Charles E Edmiston Jr², Abdul H Khan¹, Benson T Massey¹, Kulwinder S Dua¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
² Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

PMID: 25638508
DOI: 10.1016/j.gie.2014.11.006

No abstract available

MeSH terms

Adult
Aged
Aged, 80 and over
Carbapenems / pharmacology
Cholangiopancreatography, Endoscopic Retrograde / adverse effects
Cholangiopancreatography, Endoscopic Retrograde / instrumentation
Cross Infection / microbiology
Cross Infection / transmission*
Disinfection / methods
Disinfection / standards*
Duodenoscopes / microbiology*
Equipment Contamination / prevention & control*
Escherichia coli / drug effects
Escherichia coli / enzymology*
Escherichia coli / isolation & purification
Escherichia coli Infections / microbiology
Escherichia coli Infections / transmission*
Female
Guidelines as Topic
Humans
Male
Middle Aged
Young Adult
beta-Lactam Resistance
beta-Lactamases / metabolism

Substances

Carbapenems
beta-Lactamases
beta-lactamase NDM-1